Skip to main content
OpenTrials

Clinical trial condition

Infections, Rotavirus

Explore clinical trials studying Infections, Rotavirus. Study availability and eligibility vary by location and protocol.

56 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Infections, Rotavirus trial results

Completed

Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

NCT00134732

Conditions
Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations
  • GSK Investigational Site Bucheon-si, South Korea
  • GSK Investigational Site Daejeon, South Korea
  • GSK Investigational Site Jeonju, South Korea
  • GSK Investigational Site Seoul, South Korea
View Trial Details
Completed

Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

NCT00137930

Conditions
Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations
  • GSK Investigational Site Lahti, Finland
  • GSK Investigational Site Oulu, Finland
  • GSK Investigational Site Pori, Finland
  • GSK Investigational Site Tampere, Finland
View Trial Details
Completed

Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa

NCT00383903

Conditions
Infections, Infections, Rotavirus, RNA Virus Infections, +3 more
Locations
  • GSK Investigational Site Brits, South Africa
  • GSK Investigational Site Ga-Rankuwa, South Africa
  • GSK Investigational Site Pretoria, South Africa
  • GSK Investigational Site Pretoria North, South Africa
View Trial Details
Completed

Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania

NCT01253967

Conditions
Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, +6 more
Locations
  • GSK Investigational Site Bucharest, Romania
  • GSK Investigational Site Bucharest, Romania
  • GSK Investigational Site Cluj-Napoca, Romania
  • GSK Investigational Site Cluj-Napoca, Romania
View Trial Details

Related conditions